View All3 Biotech Stocks That Could Pop in a HeartbeatBiotech stocks have been on a tear lately, with the SPDR S&P Biotech (ETF) (NYSEARCA:XBI) outrunning the S&P 500 about 45% to 10% over the past 10 months.Click to Enlarge And momentum still is on biotechs’ side, with 57% of the XBI’s components trading above their respective 50-day moving average. For […]
Stock Trading Alert: Uncertainty Following Friday’s Decline – Will Downtrend Continue?By: Paul Rejczak | Mon, Mar 9, 2015SharePrintEmailStock Trading Alert originally published on March 9, 2015, 7:50 AM:Briefly: In our opinion, speculative short positions are favored (with stop-loss at 2,150 and profit target at 1,980, S&P 500 index)Our intraday outlook is bearish, and our short-term outlook is bearish:Intraday outlook (next […]
Some well-known biotechnology exchange traded funds could be stirred by Gilead Sciences (GILD) fourth-quarter earnings report released Tuesday after the close of U.S. markets.The California-based company posted net income of $3.49 billion, or $2.18 a share, compared with $791 million, or 47 cents a share, a year earlier as revenue more than doubled to $7.31 billion from $3.12 billion on […]
However, one has to be careful not to grab an ETF that sounds too “cool” or cutting-edge, because it may mean some very illiquid securities are involved and you want to stay away from those.PLUS: 10 Ways to Tax-Proof Your PortfolioInstead, I look for ETFs that are structured in a creative way to distinguish them from other ETFs that are in […]
11 ways to play biotech
The Fast Money traders discuss 11 ways to play biotech.
On a sluggish Monday for U.S. stocks, some biotechnology names shined. Celgene and Agios jumped nearly 3 percent while biotech-linked funds continued their steady climbs from last year.Acquisitions and breakthroughs abound in a sector brimming with options ripe for growth. Traders on CNBC’s “Fast Money” outlined their […]
4 Tips for Trading Biotech StocksPosted by Joe Fahmy
on January 12th, 2015
Share on StockTwitsThe Biotech sector has been a leading group for years now. I get many questions on how to trade these stocks, so here are a few tips:1) DO NOT trade anything you are not comfortable with. There is nothing worse than being nervous in a position. Why? […]
SummaryBiotech stocks should outperform the market in 2015. However the biotech sector is linked to healthcare fundamentals like government pricing policy.
The industry is better financed than any time in its history driving innovation and new product growth. The appetite for M&A and IPOs will continue.
Biopharmaceutical stocks defy traditional analysis and have been a safe haven from global economic news.
2015: Another […]
Over the last several years, there has rarely been a bad time to own biotechnology exchange traded funds. That much is confirmed by the presence of multiple biotech ETFs on the annual lists of the top 10 sector funds.In 2014, each of the five major biotech ETFs ranked among the year’s top 10 sector ETFs. That includes the First Trust […]
Best and worst ETFs in 2014
Best & worst ETFs in 2014
CNBC’s Bob Pisani discusses what was behind the strong performance of biotech ETFs in 2014 and if the NYSE will be sold off in 2015.
The exchange-traded fund winners this year were biotech and mainland China. It was a home run for biotech across the three largest ETFs.SPDR Biotech, an equal-weighted […]
View gallery.It’s been a rough couple of days for biotech stocks.To start, Gilead Sciences, Inc. (NASDAQ: GILD) has dropped from a high of almost $110 per share on Friday to a low of $86 on Tuesday.Many other big-name biotechs, such as Amgen, Inc. (NASDAQ: AMGN), Biogen Idec Inc (NASDAQ: BIIB) and Valeant Pharmaceuticals Intl Inc (NYSE: VRX) have fallen with […]
